Cargando…
Utilization and Comparative Effectiveness of Caspofungin and Voriconazole Early after Market Approval in the U.S
OBJECTIVES: Both caspofungin and voriconazole were initially approved by the FDA with very narrow indications. Our aim was to evaluate the utilization patterns and comparative effectiveness of these agents early after marketing before any labeling change occurred. METHODS: This was a retrospective c...
Autores principales: | Ascioglu, Sibel, Chan, K. Arnold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888390/ https://www.ncbi.nlm.nih.gov/pubmed/24427277 http://dx.doi.org/10.1371/journal.pone.0083658 |
Ejemplares similares
-
Are Systemic Voriconazole and Caspofungin Ototoxic? An Experimental Study with Rats
por: Aydın, Emine, et al.
Publicado: (2012) -
Impact of an electronic alert on prescription patterns of meropenem, voriconazole and caspofungin
por: Chok, Lionel, et al.
Publicado: (2021) -
Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole
por: López-Ciudad, Víctor, et al.
Publicado: (2006) -
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
por: Karthaus, M
Publicado: (2011) -
Efficacy of the Combination of Voriconazole and Caspofungin in Experimental Pulmonary Aspergillosis by Different Aspergillus Species
por: Zhang, Ming, et al.
Publicado: (2013)